FIL1h 抗体
-
- 抗原 See all FIL1h products
- FIL1h (Interleukin 1 eta (FIL1h))
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This FIL1h antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA
- 特异性
- Recognizes human IL-36beta.
- 交叉反应
- 人
- 无交叉反应
- 小鼠
- 交叉反应 （详细）
- Does not cross-react with mouse IL-36beta and IL-36gamma.
- 免疫原
- Recombinant human IL-36beta.
-
anti-Interleukin 1 eta (FIL1h) (AA 1-157) antibody
FIL1h 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 1E4 unconjugated
anti-Interleukin 1 eta (FIL1h) (C-Term) antibodyFIL1h 适用: 人, 小鼠 WB, ELISA, IHC, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interleukin 1 eta (FIL1h) (AA 1-157) antibodyFIL1h 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Interleukin 1 eta (FIL1h) (AA 1-30), (N-Term) antibodyFIL1h 适用: 人 WB, FACS 宿主: 兔 Polyclonal RB22631 unconjugated
-
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- Lot specific
- 缓冲液
- In PBS containing 10 % glycerol and 0.02 % sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
-
Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 1 year after receipt when stored at -20°C. - 有效期
- 12 months
-
- 抗原
- FIL1h (Interleukin 1 eta (FIL1h))
- 别名
- IL-36beta (FIL1h 产品)
- 别名
- 2310043N20Rik antibody, Il36b antibody, FIL1 antibody, FIL1-(ETA) antibody, FIL1H antibody, FILI-(ETA) antibody, IL-1F8 antibody, IL-1H2 antibody, IL1-ETA antibody, IL1F8 antibody, IL1H2 antibody, Il1f8 antibody, interleukin 1 family, member 8 antibody, interleukin 36 beta antibody, interleukin 36, beta antibody, Il1f8 antibody, IL36B antibody, Il36b antibody
- 背景
- IL-36alpha (IL-1F6), IL-36beta (IL-1F8) and IL-36gamma (IL-1F9) bind to IL-36R (IL-1Rrp2) and IL-1RAcP, activating similar intracellular signals as IL-1. IL-36Ra inhibits the production of proinflammatory cytokines, including IL-12, IL-1beta, IL-6, TNF-alpha and IL-23 induced by IL-36 in BMDC and CD4 T cells. Skin and dendritic cells are targets of the IL-36 interleukins leading to a Th1 response. These cytokines may represent potential targets for immune-mediated inflammatory conditions or, alternatively, could be used as adjuvants in vaccination.
-
